Pancreatic cancer stem cells: emerging target for designing novel therapy
about
Molecular therapeutics in pancreas cancerIncreased Oxidative Stress as a Selective Anticancer TherapyTargeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressivenessThe role of cancer stem cells and miRNAs in defining the complexities of brain metastasisGastric cancer stem cells: a novel therapeutic targetp-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signalingAn integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancerSonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer stem cell self-renewalStem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy.PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma.Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple OpponentsCancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.Targeting the K-Ras--JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formation.Transcriptional silencing of ETS-1 abrogates epithelial-mesenchymal transition resulting in reduced motility of pancreatic cancer cellsEmbryonic stem cell factors and pancreatic cancerJNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells.Long noncoding RNA MALAT-1 enhances stem cell-like phenotypes in pancreatic cancer cellsDKK3 blocked translocation of β-catenin/EMT induced by hypoxia and improved gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell.Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy.Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cellsBufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling.DEspR roles in tumor vasculo-angiogenesis, invasiveness, CSC-survival and anoikis resistance: a 'common receptor coordinator' paradigm.Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)The roles of FOXM1 in pancreatic stem cells and carcinogenesisTumor budding cells, cancer stem cells and epithelial-mesenchymal transition-type cells in pancreatic cancer.Role of Hippo signaling in cancer stem cells.Role of epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma: is tumor budding the missing link?Involvement of epithelial to mesenchymal transition in the development of pancreatic ductal adenocarcinoma.Role of Krüppel-like factors in cancer stem cells.Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells.Nicotine induces self-renewal of pancreatic cancer stem cells via neurotransmitter-driven activation of sonic hedgehog signalling.Polymeric Micelles of PEG-PLA Copolymer as a Carrier for Salinomycin Against Gemcitabine-Resistant Pancreatic Cancer.Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1.Pim-3 Regulates Stemness of Pancreatic Cancer Cells via Activating STAT3 Signaling Pathway.Gemcitabine treatment induces endoplasmic reticular (ER) stress and subsequently upregulates urokinase plasminogen activator (uPA) to block mitochondrial-dependent apoptosis in Panc-1 cancer stem-like cells (CSCs).c-Met in pancreatic cancer stem cells: therapeutic implications.Combinatorial effects of an epigenetic inhibitor and ionizing radiation contribute to targeted elimination of pancreatic cancer stem cell.Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-β1 signaling in pancreatic cancer.SUV420H2 is an epigenetic regulator of epithelial/mesenchymal states in pancreatic cancer.Depletion of HDAC1, 7 and 8 by Histone Deacetylase Inhibition Confers Elimination of Pancreatic Cancer Stem Cells in Combination with Gemcitabine.
P2860
Q26751709-C6048EA8-40AC-44CC-95D5-CB4279BE6D72Q26798210-5491CC6E-9DE5-4A1B-B127-4FB1DC95E9A1Q26822776-21A6EA7D-01E7-402E-84A0-AB9422C86BC6Q26864372-1D8D939E-1653-494A-A8C0-55C67E69D573Q27002840-FD24DE07-774B-4A28-B7EE-C08CDE8969B5Q28269527-D5D407AA-D8E3-4FF1-B0D6-459A467F180CQ28392205-F50CD39D-2560-452B-89DE-26A24636AE7AQ28484138-02069951-AF6C-4B0C-8A22-225DEED11327Q33653485-F7ACB120-82C3-4BE7-B5D8-1C8906AB1C5FQ33689649-386C426F-6F9A-4B90-AE4B-3C2AA6239655Q33704284-202E1EFC-1262-4E13-9A70-C4CD3BE62C20Q34067873-F41C8A5B-6408-4D65-9056-771C220BDA58Q34104152-A48BDB3B-F751-4BD1-9F67-EB9453348341Q35012520-6C426244-8474-4359-907D-D58F8E781188Q35113612-217F7CAB-5E72-499A-B1BE-75A1B35398D9Q35238494-50160028-43CA-4234-96DC-5231986EAD25Q35585395-F4788329-1DFF-4E06-9437-61BBE4F9B723Q36394714-5A8E51B6-FB9B-4108-BBD2-BF36FDCD6730Q37070323-CE3A23DE-E883-4D19-9608-E2180E8DD3AAQ37178822-E9130DD5-072F-41F9-805D-629139FB976FQ37190831-67C66352-C22B-4127-B332-4E36B08DBEE3Q37499770-4352EC70-D4CC-45A5-8F8E-76D4AF2EBE92Q37501848-24CF8AEB-5BFD-470E-BFDA-2586B1BF3F99Q37583296-62785F6F-930A-4237-91BB-F50C9D670488Q38073775-592B12F7-D454-4C9F-8C90-168E46823CFCQ38137820-D3F5CC2C-4366-4A65-A1D0-DE2D92D1C3CFQ38142155-8E34714F-8570-4C4D-9C96-63E8CE5B337EQ38248759-89E2782C-AA4A-4067-A30D-1B0FE3AFB021Q38330372-4E142844-23A3-488B-A648-93C158C739B3Q38714521-7B990F07-8EF0-4500-A45E-3D3B571C46C2Q38810062-ECED9601-F941-43BB-B260-ECDCF69184A2Q38847679-4F2A844F-6E58-499E-A92F-3CA324F1197CQ39005681-F0272AC1-2559-4F37-9EDC-35632BFD026CQ41180138-14989845-DDFC-4995-A922-79DC4C342F53Q41561405-BD8F90D5-F729-4E84-9EEC-80CE90695666Q42426376-6E117646-E783-4737-8547-038B19F3B7E8Q47096734-D09BBCBC-CEA0-44FF-B710-D85EFA442DCEQ47161568-0CD36469-EBE2-40EE-9A73-7F900334FF1CQ47327498-56079A32-DDE8-4F6C-898F-431903291CFCQ48157879-2AF82926-1E82-490C-B6D1-D77BB8084EB8
P2860
Pancreatic cancer stem cells: emerging target for designing novel therapy
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pancreatic cancer stem cells: emerging target for designing novel therapy
@ast
Pancreatic cancer stem cells: emerging target for designing novel therapy
@en
Pancreatic cancer stem cells: emerging target for designing novel therapy
@nl
type
label
Pancreatic cancer stem cells: emerging target for designing novel therapy
@ast
Pancreatic cancer stem cells: emerging target for designing novel therapy
@en
Pancreatic cancer stem cells: emerging target for designing novel therapy
@nl
prefLabel
Pancreatic cancer stem cells: emerging target for designing novel therapy
@ast
Pancreatic cancer stem cells: emerging target for designing novel therapy
@en
Pancreatic cancer stem cells: emerging target for designing novel therapy
@nl
P2093
P2860
P3181
P1433
P1476
Pancreatic cancer stem cells: emerging target for designing novel therapy
@en
P2093
Aamir Ahmad
Dejuan Kong
Fazlul H. Sarkar
P2860
P304
P3181
P356
10.1016/J.CANLET.2012.03.018
P407
P577
2013-09-10T00:00:00Z